BRL 43694.
D000970:Antineoplastic Agents / Q000009:adverse effects; D017829:Granisetron; D006801:Humans; D007191:Indazoles / Q000627:therapeutic use*; D011720:Pyrazoles / Q000627:therapeutic use*; D012702:Serotonin Antagonists / Q000627:therapeutic use*; D014839:Vomiting / Q000517:prevention & control*
D000970:Antineoplastic Agents; D017829:Granisetron; D007191:Indazoles; D011720:Pyrazoles; D012702:Serotonin Antagonists